Allogene Therapeutics, Inc. 10-Q filing
Filed 2025-08-13 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001737287-25-000088
- Form type
- 10-Q
- CIK
- 0001737287
- Primary document
- https://www.sec.gov/Archives/edgar/data/1737287/000173728725000088/allo-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Allogene Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-122.0M | - | - |
| Net Income | $-110.7M | - | - |
| Eps Basic | -0.51 | - | - |
| Eps Diluted | -0.51 | - | - |
| Cash And Equivalents | $52.3M | - | - |
| Total Assets | $470.6M | - | - |
| Total Liabilities | $126.0M | - | - |
| Shareholders Equity | $344.6M | - | - |
| Operating Cash Flow | $-92.0M | - | - |
| Capital Expenditures | $143,000 | - | - |